| P50 | author | Clara D. Bloomfield | Q4793409 |
| | Albert de la Chapelle | Q5618748 |
| | Sandya Liyanarachchi | Q43376214 |
| | Krzysztof Mrózek | Q66385542 |
| | Ramana V Davuluri | Q89014659 |
| | Herbert Auer | Q91733852 |
| | Michael A Caligiuri | Q97333782 |
| | Amy S Ruppert | Q114341048 |
| | Claudia D Baldus | Q114529739 |
| | Stephan M. Tanner | Q114529751 |
| | Martin Guimond | Q125296596 |
| P2093 | author name string | Nehad Mohamed | |
| P2860 | cites work | Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection | Q27860727 |
| | The DNA sequence of human chromosome 21 | Q28145358 |
| | Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461) | Q28209814 |
| | An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation | Q28253702 |
| | Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia | Q33330210 |
| | The role of chromosome translocations in leukemogenesis. | Q33793085 |
| | Assembly of microarrays for genome-wide measurement of DNA copy number | Q34099918 |
| | Regulation of amyloid precursor protein expression and secretion via activation of ERK1/2 by hepatocyte growth factor in HEK293 cells transfected with APP751. | Q34210522 |
| | The biological role of the Alzheimer amyloid precursor protein in epithelial cells | Q34589247 |
| | New mechanisms of AML1 gene alteration in hematological malignancies | Q35046095 |
| | Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis | Q36400886 |
| | MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia | Q38294261 |
| | Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH. | Q38487721 |
| | Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q. | Q38489443 |
| | Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation | Q40617477 |
| | Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma | Q40635674 |
| | ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway | Q40674424 |
| | Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo | Q40815925 |
| | High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization | Q41048598 |
| | Oncogenic transcription factors in the human acute leukemias | Q41628889 |
| | The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome | Q42798732 |
| | CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). | Q44068434 |
| | Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia | Q44449269 |
| | Amplification of ETS2 oncogene in acute nonlymphoblastic leukemia with t(6;21;18) | Q45100648 |
| | Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells | Q47571879 |
| | Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome | Q70908071 |
| | Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2 | Q73942158 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | karyotype | Q189967 |
| | leukemia | Q29496 |
| | acute myeloid leukemia | Q264118 |
| | overexpression | Q61643320 |
| P304 | page(s) | 3915-3920 | |
| P577 | publication date | 2004-03-08 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes | |
| P478 | volume | 101 | |